Recommend to a friend

Pulmonologists as the Gatekeepers of Precision Medicine

Presented by: Momen M. Wahidi, MD, FCCP and W. Dean Wallace, MD Biomarker-driven targeted therapy of patients with NSCLC requires accurate diagnosis and staging. The pulmonary care team must acquire adequate biopsy tissue to enable histology, immunofluorescence and molecular biomarker testing. Presented in Los Angeles, California - October 2016.

Friend's Name :
Friend's email :
You may provide a message here that will be included in the emailed recommendation. (2000 Character Max) Characters written:
Your comment